Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain E/I Balance Modulation in ASD
NCT03678129Completed
- Sponsor
- King's College London
- Start
- Dec 2018
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing AZD7325 Cohort with Clobazam Cohort (2 cohorts). Primary endpoints: Brain activation and connectivity response to GABAergic stimulation up to 1 year, Brain electrophysiological activity task-free electroencephalography up to 1 year and 1 more. Started Dec 2018; status: completed.
02
Drugs
clobazamazd7325
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03678129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678129.